Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report) shares crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.01 and traded as high as $0.01. Evofem Biosciences shares last traded at $0.01, with a volume of 52,362 shares.
Evofem Biosciences Price Performance
The business’s 50-day moving average price is $0.01 and its 200-day moving average price is $0.01. The firm has a market capitalization of $1.08 million, a PE ratio of -0.02 and a beta of -0.90.
Evofem Biosciences Company Profile
Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
Further Reading
- Five stocks we like better than Evofem Biosciences
- The Role Economic Reports Play in a Successful Investment Strategy
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- What is a SEC Filing?
- How Do Stock Buybacks Affect Shareholders?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
